Sign up to our newsletter
and receive exclusive information and discount coupons straight to your inbox

News tag: aducanumab


New drug for Alzheimer’s looked upon with careful optimism

25 Mar, 2015 | by Ion Gireada | 0 comments
A new drug promoted as able to treat early stage Alzheimer’s may not be as effective as initially announced. Aducanumab, developed by Biogen, a Cambridge, Massachusetts biotech company, acts as a monoclonal antibody, and has shown impressive results in early tests on patients with early stages of the disease. The…